Terms: = Endocrine gland cancer AND MUC16, CA125, CA-125 AND Prognosis
692 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
3. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer.
Wu M; Gu S; Yang J; Zhao Y; Sheng J; Cheng S; Xu S; Wu Y; Ma M; Luo X; Zhang H; Wang Y; Zhao A
BMC Cancer; 2024 Feb; 24(1):267. PubMed ID: 38408960
[TBL] [Abstract] [Full Text] [Related]
5. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
6. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
Chen SJ; Ren LK; Fei XB; Liu P; Wang X; Zhu CH; Pan YZ
Aging (Albany NY); 2024 Feb; 16(3):2617-2637. PubMed ID: 38305809
[TBL] [Abstract] [Full Text] [Related]
7. Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
[TBL] [Abstract] [Full Text] [Related]
8. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of ca125, HE4, and C5a.
Shi H; Liu L; Deng X; Xing X; Zhang Y; Djouda Rebecca Y; Han L
J Ovarian Res; 2024 Jan; 17(1):4. PubMed ID: 38178252
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to ca125.
AlSomairi A; Himayda S; Altelmesani A; Lee YJ; Lee JY
Gynecol Oncol; 2024 Feb; 181():155-161. PubMed ID: 38176127
[TBL] [Abstract] [Full Text] [Related]
10. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].
Zhang YL; Xia XK; Zhang M
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):930-938. PubMed ID: 38123199
[No Abstract] [Full Text] [Related]
11. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Wang H; Chen C; Wang D; Zhu Y; Chen P
BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
[TBL] [Abstract] [Full Text] [Related]
12. Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer.
Vilming B; Fallås Dahl J; Bentzen AG; Ingebrigtsen VA; Berge Nilsen E; Vistad I; Dørum A; Solheim O; Bjørge L; Zucknick M; Aune G; Lindemann K
Int J Gynecol Cancer; 2023 Dec; 33(12):1898-1905. PubMed ID: 38000795
[TBL] [Abstract] [Full Text] [Related]
13. Sequential high-intensity focused ultrasound treatment combined with chemotherapy for inoperable pancreatic cancer: a retrospective analysis for prognostic factors and survival outcomes.
Dong S; Zhong A; Zhu H; Wang K; Cheng CS; Meng Z
Int J Hyperthermia; 2023; 40(1):2278417. PubMed ID: 37945310
[TBL] [Abstract] [Full Text] [Related]
14. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
[TBL] [Abstract] [Full Text] [Related]
15. Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian cancer in the UK: Results From the KNOW-OC Survey.
Fotopoulou C; Hall M; Lord R; Miller R; Sundar S; Roebuck N; Fildes L; Wesselbaum A; McCormack S; Hickey J; Ledermann J
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):e1-e10. PubMed ID: 37923688
[TBL] [Abstract] [Full Text] [Related]
16. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma.
Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
18. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (ca125, HE4, mesothelin).
Klotz DM; Link T; Wimberger P; Kuhlmann JD
Clin Chem Lab Med; 2024 Feb; 62(3):530-539. PubMed ID: 37816681
[TBL] [Abstract] [Full Text] [Related]
19. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer.
Zhang B; Chen X; Wang Z; Guo F; Zhang X; Huang B; Ma S; Xia S; Shang D
Aging (Albany NY); 2023 Oct; 15(19):10549-10579. PubMed ID: 37815881
[TBL] [Abstract] [Full Text] [Related]
20. Serum ca125 level as predictors of the efficacy of olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer.
Asano F; Momomura M; Morisada T; Tsushima K; Haruna Y; Shibuya H; Matsumoto H; Kobayashi Y
J Obstet Gynaecol Res; 2023 Dec; 49(12):2883-2888. PubMed ID: 37735981
[TBL] [Abstract] [Full Text] [Related]
[Next]
